It is worth noting that targeting CcO is an important pathway for improving AD, as mitochondrial dysfunction and decreased CcO activity have been observed in brains with AD (Perez‐Gracia, Torrejon‐Escribano, & Ferrer, 2008). The gene discussed is RYR1; the disease is Alzheimer disease.